# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HCA Healthcare Q3 earnings eyed at $5.72 per share, backed by patient growth, DPP contributions, and favorable payor trends.
Retail investors prepare for the first busy week in the Q3 earnings season, with Tesla, Netflix and Intel on deck.
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $425 to $475.
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $438 to $495.
Goldman Sachs analyst Scott Fidel assumes HCA Healthcare (NYSE:HCA) with a Buy rating and announces Price Target of $470.
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $370 ...
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from ...